Brighter Light, Faster Results: What New Research Says About Treating Newborn Jaundice

A 2026 review that pooled 12 studies of 1,144 babies asked whether stronger phototherapy works better than gentler light

A large 2026 research review combined the results of 12 earlier studies involving 1,144 newborns and found that stronger, higher-dose phototherapy lowers jaundice faster and shortens treatment time compared with gentler, lower-dose light. The benefit was largest for premature babies and those with the most severe jaundice. For many full-term babies with mild jaundice, ordinary phototherapy still works perfectly well [1].

Why Newborn Jaundice Matters

Most parents of a newborn will hear the word "jaundice" within a few days of birth. It refers to a yellow tint in a baby's skin and eyes caused by a substance called bilirubin, which the body makes naturally when it recycles old red blood cells. A newborn's liver is still learning to clear bilirubin, so it can build up. Mild jaundice is extremely common and harmless, affecting somewhere between a quarter and a half of full-term babies and even more premature ones [1]. But when bilirubin climbs very high, it can cross into the brain and cause lasting injury — a rare but serious condition. That risk is why hospitals watch bilirubin levels so carefully and why jaundice is one of the most common reasons a newborn is admitted or brought back to hospital around the world, with the heaviest toll in lower-income regions [2].

How Doctors Have Treated Jaundice Over Time

The main treatment for jaundice is beautifully simple in principle: light. Special blue light shone on a baby's skin changes the bilirubin into a form the body can wash out easily, without waiting for the liver to do all the work. This treatment, called phototherapy, has been used for decades and has been one of medicine's quiet success stories — it has made the older, riskier "exchange transfusion" (replacing the baby's blood) a rare event and has dramatically reduced cases of jaundice-related brain injury in well-equipped hospitals [3]. Over the years, national guidelines spelled out when to start the lights and how to set them up — the right color of light, keeping the light close enough, and watching the baby's temperature [3].

But there was a long-running, under-appreciated question hiding inside this everyday treatment: how bright should the light be? Scientists have known since the early days of phototherapy that "more light" generally means faster results [4], and careful hospital studies confirmed that the higher the dose of light reaching the skin, the quicker the bilirubin falls [5]. Doctors began distinguishing "intensive" phototherapy (a strong dose of light) from "conventional" phototherapy (a gentler dose). Yet earlier attempts to sum up the evidence often compared the type of lamp or the place of treatment — hospital versus home, one lamp versus two — rather than the actual strength of the light delivered. That left families and clinicians without a clear answer to a basic question. The 2026 review was built to answer it directly.

What the Researchers Did

A team of neonatal doctors in China gathered every suitable study they could find, from the databases' beginnings up to March 2026, that compared strong light against gentler light in jaundiced newborns [1]. They combined 12 studies — 8 of them randomized controlled trials, the most rigorous kind, and 4 that observed babies in real-world care — covering 1,144 infants in a dozen countries, from Italy and the United States to Nigeria and Indonesia. "Intensive" was defined by a specific brightness measurement, so that every study was sorted by the true dose of light rather than by brand or setting. The researchers then measured two things families care about most: how far the bilirubin level dropped, and how long each baby needed to stay under the lights. Combining many studies this way is powerful because it pools thousands of data points, though it also mixes together babies and hospitals that differ in many ways — something the team was careful to acknowledge.

What They Found

Stronger light worked faster. On average, babies treated with intensive phototherapy had their bilirubin fall noticeably more than babies on gentler light over the same stretch of time [1]. Just as importantly for tired parents, intensive treatment tended to be shorter — by roughly 20 hours on average where treatment time was recorded. That is nearly a day less under the lights, which can mean less separation from parents, fewer interruptions to feeding and cuddling, and an earlier trip home.

To put the numbers in everyday terms, imagine two babies with similar jaundice, one under a gentle light and one under a strong light. Over the same period, the baby under the stronger light would typically have a lower bilirubin level by the end, and would often be finished with treatment sooner. The researchers also looked carefully to make sure the result was not being driven by any single unusual study, and they checked for the kind of lopsided reporting that can bias this type of review — neither problem was found, which makes the overall finding more trustworthy even though the individual studies varied a lot in how they were run.

The most useful discovery was which babies gained the most. Two groups stood out. Premature babies benefited far more from stronger light than full-term babies did. And babies who started with the highest bilirubin levels — the ones who were most jaundiced — improved the most from the intensive approach [1]. In other words, the sicker and the more premature the baby, the bigger the advantage of making sure the light is genuinely strong. For a healthy full-term baby with only mild jaundice, the gentler approach was still enough.

What This Means for Your Baby

If your baby is premature or has a high bilirubin level, this research supports doctors making sure the phototherapy is truly delivering a strong dose — for example by exposing more of the baby's skin, positioning the lights closer, or using lights above and below. The idea that the strength of the light matters more than the brand of machine is now backed by several lines of evidence, including a landmark trial showing that even filtered sunlight worked as well as hospital lamps once the dose was strong enough [6], and studies showing two lamps outperform one, especially for premature babies [7]. If your baby is a healthy full-term newborn with mild jaundice, gentler phototherapy is likely all that is needed, and there is no reason for alarm.

It is also worth knowing that stronger is not always better for every baby. Very bright light can put a little extra stress on a newborn's body chemistry [8], so the aim is to match the dose to the baby's needs, not to blast every infant with maximum light. And while home phototherapy is convenient and appealing, the research suggests home treatment — where the light's true strength is often not measured — can take longer and sometimes leads to a return to hospital [9]. None of this should worry a family whose baby is doing well; it simply explains why your care team may recommend hospital treatment for a baby who is premature or more deeply jaundiced.

What Researchers Are Working On Next

The honest bottom line is that this review answers one question well and opens others. Because it pooled studies of many different kinds and ages — some going back to the 1990s — the results should be read as a strong, encouraging signal rather than the final word. The studies measured the bilirubin number, not long-term outcomes like how children develop years later, and severe jaundice still causes preventable harm in parts of the world with the fewest resources [10]. Guidelines continue to be refined to help doctors decide exactly when and how hard to treat [11], and new trials are testing practical, lower-cost ways to deliver strong-enough light where it is needed most, including fresh studies of sunlight-based treatment [12]. For now, the reassuring message for families is clear: phototherapy is safe and effective, and when a baby truly needs it, making the light strong enough — especially for premature and severely jaundiced infants — helps bring jaundice down faster and sends families home sooner [1].

References

  1. Qiao Y, Song M, Lu G, Liu F, Cao H, Yang M. Intensive versus conventional phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis of RCTs and cohort studies. Front Med. 2026;13:1862217. doi:10.3389/fmed.2026.1862217 ↩
  2. Slusher TM, Zamora TG, Appiah D, et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr Open. 2017;1:e000105. doi:10.1136/bmjpo-2017-000105 ↩
  3. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297–316. doi:10.1542/peds.114.1.297 ↩
  4. Ennever JF. Blue light, green light, white light, more light: treatment of neonatal jaundice. Clin Perinatol. 1990;17:467–81. doi:10.1016/S0095-5108(18)30579-730579-7) ↩
  5. Vandborg PK, Hansen BM, Greisen G, Ebbesen F. Dose-response relationship of phototherapy for hyperbilirubinemia. Pediatrics. 2012;130:e352–7. doi:10.1542/peds.2011-3235 ↩
  6. Slusher TM, Vreman HJ, Brearley AM, et al. Filtered sunlight versus intensive electric powered phototherapy in moderate-to-severe neonatal hyperbilirubinaemia: a randomised controlled non-inferiority trial. Lancet Glob Health. 2018;6:e1122–31. doi:10.1016/S2214-109X(18)30373-530373-5) ↩
  7. Nizam MA, Alvi AS, Hamdani MM, et al. Efficacy of double versus single phototherapy in treatment of neonatal jaundice: a meta-analysis. Eur J Pediatr. 2020;179:865–74. doi:10.1007/s00431-020-03583-x ↩
  8. El-Farrash RA, El-Shimy MS, Tawfik S, et al. Effect of phototherapy on oxidant/antioxidant status: a randomized controlled trial. Free Radic Res. 2019;53:179–86. doi:10.1080/10715762.2018.1549364 ↩
  9. Li R, Li T, Yan X, et al. Efficacy of home phototherapy versus inpatient phototherapy for neonatal hyperbilirubinemia: a systematic review and meta-analysis. Ital J Pediatr. 2024;50:37. doi:10.1186/s13052-024-01613-0 ↩
  10. Olusanya BO, Kaplan M, Hansen TWR. Neonatal hyperbilirubinaemia: a global perspective. Lancet Child Adolesc Health. 2018;2:610–20. doi:10.1016/S2352-4642(18)30139-130139-1) ↩
  11. Bhutani VK, Wong RJ, Turkewitz D, et al. Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation: technical report. Pediatrics. 2024;154:e2024068026. doi:10.1542/peds.2024-068026 ↩
  12. Olusanya BO, Omololu OM, Osamebor FB, et al. Filtered-sunlight phototherapy for newborns with moderate-to-severe hyperbilirubinemia: a randomized trial. Pediatr Res. 2026;99:174–82. doi:10.1038/s41390-025-04207-6 ↩